SGLT2 Inhibitors May Have Clinical Benefits For Patients with Diabetes After Myocardial Infarction
Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with a lower risk of major cardiovascular events or hospitalization for heart failure in...

ACLM launches project remission for Type 2 diabetes
Personalising diabetes care: a holistic approach to cardiometabolic health
Study Links Diabetes Distress to Blood Sugar Levels in Teens, With a Clear Target for Intervention
Newly diagnosed with diabetes? It’s time to call your financial advisor
BC Gov News